Parametric Portfolio Associates’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,012
Closed -$2.13M 4035
2019
Q3
$2.13M Buy
22,012
+222
+1% +$22.2K ﹤0.01% 2595
2019
Q2
$2.23M Buy
21,790
+2,156
+11% +$233K ﹤0.01% 2600
2019
Q1
$2.24M Buy
19,634
+4,336
+28% +$319K ﹤0.01% 2595
2018
Q4
$599K Buy
15,298
+4,994
+48% +$217K ﹤0.01% 3228
2018
Q3
$562K Sell
10,304
-4,156
-29% -$284K ﹤0.01% 3365
2018
Q2
$1.2M Buy
14,460
+6,554
+83% +$506K ﹤0.01% 2957
2018
Q1
$526K Buy
+7,906
New +$457K ﹤0.01% 3327
2017
Q4
Sell
-16,226
Closed -$1.45M 3969
2017
Q3
$1.45M Buy
+16,226
New +$1.23M ﹤0.01% 2794
2016
Q2
Sell
-10,046
Closed -$296K 3982
2016
Q1
$296K Buy
+10,046
New +$317K ﹤0.01% 3613

Parametric Portfolio Associates's ONCE Position: Q4 2019 in Review

Parametric Portfolio Associates sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 22,012 shares — an estimated $2.13M sold.

Parametric Portfolio Associates first reported a position in ONCE in Q1 2016 and held it in 9 quarters. The position peaked at $2.24M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Parametric Portfolio Associates reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 22,012 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.13M.
  • Parametric Portfolio Associates first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 9 quarters.
  • Parametric Portfolio Associates's Spark Therapeutics, Inc. Common Stock position peaked at $2.24M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Parametric Portfolio Associates's 13F filing for Q4 2019, filed 14 Feb 2020.